International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation
Antonio Palumbo(University Hospital Brno), Robert Z. Orlowski(University of North Carolina at Chapel Hill), Hermann Einsele(Universitätsklinikum Würzburg), Jesús F. San Miguel(Clinica Universidad de Navarra), Sagar Lonial(Emory University), Alessandra Larocca(Cornell University), Brian G.M. Durie(Cedars-Sinai Medical Center), Kenneth C. Anderson(Dana-Farber Cancer Institute), Meletios Α. Dimopoulos(Korea University), Paul G. Richardson(Harvard University), S. Vincent Rajkumar(WinnMed), Michèle Cavo(Unknown), Rubén Niesvizky(Cornell University), Ola Landgren(University of Miami Health System), Roman Hájek(University Hospital Ostrava), Gareth J. Morgan(Hywel Dda University Health Board), Kazuyuki Shimizu(Spanish Head & Neck Cancer Cooperative Group), Philippe Moreau(Centre National de la Recherche Scientifique), Andrew Spencer(The Alfred Hospital), A. Keith Stewart(The University of Texas MD Anderson Cancer Center), Pieter Sonneveld(Erasmus MC Cancer Institute)
Cited by 384
Related Papers
The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report
|The Lancet|2019|3k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k